These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2881976)

  • 1. Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.
    Hyttel J; Arnt J
    J Neural Transm; 1987; 68(3-4):171-89. PubMed ID: 2881976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
    Billard W; Ruperto V; Crosby G; Iorio LC; Barnett A
    Life Sci; 1984 Oct; 35(18):1885-93. PubMed ID: 6387355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo.
    Andersen PH; Grønvald FC
    Life Sci; 1986 Apr; 38(16):1507-14. PubMed ID: 2871467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
    Arnt J; Hyttel J
    Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiography of dopamine receptors and dopamine uptake sites in the spontaneously hypertensive rat.
    Kujirai K; Przedborski S; Kostic V; Jackson-Lewis V; Fahn S; Cadet JL
    Brain Res Bull; 1990 Nov; 25(5):703-9. PubMed ID: 2149666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
    Hensler JG; Cotterell DJ; Dubocovich ML
    J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O; Parkinson D; Nielsen M
    Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase.
    Filloux F; Dawson TM; Wamsley JK
    Brain Res Bull; 1988 Apr; 20(4):447-59. PubMed ID: 3135077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]SCH 23390 identifies D-1 binding sites in rat striatum and other brain areas.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1986 Dec; 38(12):907-12. PubMed ID: 2880965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.
    McQuade RD; Ford D; Duffy RA; Chipkin RE; Iorio LC; Barnett A
    Life Sci; 1988; 43(23):1861-9. PubMed ID: 2904635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):273-7. PubMed ID: 2110042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D1 dopamine receptors in the rat retina: effect of dark adaptation and chronic blockade by SCH 23390.
    Porceddu ML; De Montis G; Mele S; Ongini E; Biggio G
    Brain Res; 1987 Oct; 424(2):264-71. PubMed ID: 2960425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of 7-[3-(4-[2,3-dimethylphenyl]piperazinyl)-propoxy]-2(1H)-quinolinone binding in rat striatum: effects of lesions.
    Zhang X; Nakata Y; Kikuchi T; Segawa T
    Pharm Res; 1990 Mar; 7(3):280-2. PubMed ID: 1971105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.